BrokerTH
The SET Index closed August 19 at 1,626.26 — working within a tight range of 1,610 to 1,630 that has held for most of the second half of August 2026. On August 18, the index briefly touched 1,630.87 before pulling back. That intraday high is the technical level every Thai equity investor is watching: a confirmed close above 1,630 would be the first meaningful upside breakout in weeks, and the sector that leads it matters for how you position now.
Why 1,630 Is a Real Resistance Level
The 1,630 zone has acted as a ceiling multiple times since June 2026. The pattern is consistent: the SET approaches 1,630, volume thins, and sellers emerge. The most recent intraday touch of 1,630.87 on August 18 was a higher high versus the August 13 level of 1,612.62 and the August 5 close of 1,617.13 — the overall market is making progress, but it is doing so in fits and starts.
The math is straightforward: 1,630 has been tested and failed four times. Markets that fail repeatedly at a level tend to break it eventually — but they also tend to shake out impatient buyers before they do. Wait for confirmation before declaring the breakout real.
What Has Been Dragging the SET Below 1,630
Foreign investors have been consistent net sellers of Thai equities throughout August. This is partly a function of the rate differential — with Thai bond yields below comparable US yields by 200bps, global capital has less reason to hold Thai risk assets. When foreign sellers are persistent, domestic buying needs to be strong enough to absorb the pressure and then some.
Middle East tension and the associated oil price uncertainty are a second drag. Thailand is a net oil importer, and when Brent crude spikes on Iran risk, the market reprices energy cost risk downward for Thai industrials, transport, and consumer staples names simultaneously.
Q2 earnings season contributed mixed signals: some sectors delivered above-consensus results (banking, tourism-adjacent), while others (energy, property) came in below. The net effect has been a market that feels like it wants to go up but keeps running into fundamental hurdles.
Which Sectors Could Lead a Breakout Above 1,630
Banking: Thai banks reported solid Q2 results on the back of loan growth and fee income. The sector’s weight in the SET is significant enough that banking strength alone can push the index through resistance. Watch KBank, SCB, and Krungthai specifically — they have lagged their Q2 results in price terms, which historically precedes a catch-up move.
Tourism and hospitality: Thailand’s international arrivals are recovering toward pre-2020 levels. Hotel and airline names that beat Q2 estimates have further upside if August tourism data (released in early September) shows continued momentum. Central Group’s hotel subsidiaries and Thai Airways are two names institutional buyers have been accumulating.
Healthcare: Defensive growth in a volatile macro environment. Thailand’s medical tourism sector continues to generate cash flow that domestic equity does not fully price. Bangkok Dusit Medical Services (BDMS) and Bumrungrad International are the SET’s largest healthcare names and both have institutional demand from regional investors.
What Would Prevent the Breakout
A confirmed Fed September hike would likely trigger additional foreign selling and push the SET back toward 1,610. An oil spike above $90/barrel would compress margins across energy-intensive sectors. Either catalyst could reset the market back to the lower end of the current range and delay the breakout by four to six weeks.
The Technical Setup and What to Do With It
The SET is in a position where the next 5-10 points in either direction will define the trade for the next month. A daily close above 1,635 on volume above the 20-day average would be a credible breakout signal — buy in tranches rather than all at once, with a stop below 1,610. A close below 1,610 would confirm the range is failing lower, and the next meaningful support sits at 1,590.
For longer-term investors, the SET at 1,626 on an estimated P/E of roughly 15x 2026 earnings is not expensive by regional standards. The case for a patient position with 6-12 month horizon is reasonable — but you need to be comfortable sitting through the 1,610–1,630 chop until the macro picture clarifies.
